1. Home
  2. PL vs MDGL Comparison

PL vs MDGL Comparison

Compare PL & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$41.29

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$510.75

Market Cap

11.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PL
MDGL
Founded
2010
2011
Country
United States
United States
Employees
970
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
11.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
PL
MDGL
Price
$41.29
$510.75
Analyst Decision
Buy
Strong Buy
Analyst Count
12
12
Target Price
$27.64
$674.45
AVG Volume (30 Days)
7.8M
257.6K
Earning Date
06-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.32
EPS
N/A
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$42.29
$58.39
Revenue Next Year
$30.22
$48.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.47
$265.00
52 Week High
$43.31
$615.00

Technical Indicators

Market Signals
Indicator
PL
MDGL
Relative Strength Index (RSI) 57.77 48.05
Support Level $32.23 $502.45
Resistance Level $41.71 $556.79
Average True Range (ATR) 3.73 21.93
MACD 0.21 -1.40
Stochastic Oscillator 65.91 28.49

Price Performance

Historical Comparison
PL
MDGL

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: